Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Genomic Health, Inc.    GHDX   US37244C1018

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
03/23/2015 03/24/2015 03/25/2015 03/26/2015 03/27/2015 Date
31.95(c) 31.64(c) 30.66(c) 29.66(c) 30.21(c) Last
153 843 188 393 159 675 197 171 108 061 Volume
-0.59% -0.97% -3.10% -3.26% +1.85% Change
More quotes
Financials ($)
Sales 2015 300 M
EBIT 2015 -20,2 M
Net income 2015 -20,1 M
Debt 2015 2,15 M
Yield 2015 -
Sales 2016 341 M
EBIT 2016 3,00 M
Net income 2016 1,99 M
Debt 2016 2,85 M
Yield 2016 -
PER 2015 -
PER 2016 408,80
EV / Sales 2015 3,25x
EV / Sales 2016 2,85x
Capitalization 972 M
More Financials
Company
Genomic Health, Inc. is a global healthcare company that provides actionable genomic information to personalize cancer treatment decisions.The company has a robust pipeline focused on developing tests to optimize the treatment of renal cell cancers, as well as additional treatment decisions in... 
More about the company
Surperformance© ratings of Genomic Health, Inc.
Trading Rating : Investor Rating :
More Ratings
Latest news on GENOMIC HEALTH, INC.
03/25 GENOMIC HEALTH : Multiple Data Presentations Demonstrate Positive Direct Patient..
03/20 GENOMIC HEALTH : Multiple Data Presentations Demonstrate Positive Direct Patient..
02/20 GENOMIC HEALTH : Change in Directors or Principal Officers (form 8-K)
02/16 GENOMIC HEALTH : Announces Year-End 2014 Financial Results, Provides 2015 Financ..
02/15 GENOMIC HEALTH : Recaps Year-End 2014 Financial Results
02/13 GENOMIC HEALTH : Reports Year-End 2014 Financial Results
02/11 GENOMIC HEALTH : Following NICE's Exclusive Recommendation, NHS England Agrees t..
02/11 GENOMIC HEALTH : Announces Year-End 2014 Financial Results
More news
Sector news : Biotechnology & Medical Research - NEC
03/27 ISIS PHARMACEUTICALS : Earnings Coverage - Isis Pharma
03/26 Alliance invokes Elliott track record in appeal against board shake-up
03/26 ACTELION : receives marketing approval for Opsumit (macitentan) in pulmonary art..
More sector news : Biotechnology & Medical Research - NEC
News from SeekingAlpha
02/12 GENOMIC HEALTH : 2014 Financial Results Predict Strong 2015
02/11 Genomic Health net loss improves in Q4
02/10 Genomic Health's (GHDX) CEO Kim Popovits on Q4 2014 Results - Earnings Call T..
02/10 Genomic Health (GHDX) Q4 2014 Results - Earnings Call Webcast
02/10 Genomic Health beats by $0.03, misses on revenue


Comments 
Advertisement
Chart GENOMIC HEALTH, INC.
Duration : Period :
Genomic Health, Inc. Technical Analysis Chart | GHDX | US37244C1018 | 4-Traders
Full-screen chart
Technical analysis trends
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF